Home Blog Page 259

Saw X image features Shawnee Smith as Amanda Young

By
NT Editor
-
0
Saw X image features Shawnee Smith as Amanda Young

A new image from Saw X, the tenth film in the Saw franchise, shows Shawnee Smith, reprising the role of Amanda Young

The trailer for the new film in the Saw franchise – which is going by the title Saw X since it’s the tenth installment – arrived online over the weekend, giving a preview of this story that’s set between the events of the first Saw and Saw II. Now a new image from the film has been unveiled, giving a look at a character who is able to return to the series because of its place in the timeline: Amanda Young, played by Shawnee Smith! The image can be seen at the bottom of this article. Saw X is set to reach theatres on September 29th.

Amanda was previously seen in Saw, Saw II, Saw III, and Saw VI. The character didn’t make it out of III alive (and neither did John “Jigsaw” Kramer).

Saw VI and Saw: The Final Chapter director Kevin Greutert (who also edited the first five films, plus Jigsaw) is back at the helm for Saw X. Jigsaw and Spiral: From the Book of Saw screenwriters Pete Goldfinger and Josh Stolberg have written the script. Stolberg has promised that this movie “is gonna make John Kramer fans very happy!” It has been said that “The upcoming Saw movie is planned to be very much a John Kramer story … The idea is that the story is being told from Kramer’s point of view as opposed to following the trap victims.”

Here’s the synopsis: In the Twisted Pictures next installment John Kramer (Tobin Bell) is back, and it’s the untold chapter of Jigsaw’s final games. Set between the events of Saw I and II, a sick and desperate John travels to Mexico for a risky and experimental medical procedure in hopes of a miracle cure for his cancer – only to discover the entire operation is a scam to defraud the most vulnerable. The infamous serial killer returns to his work, turning the tables on the con artists in his signature visceral way through devious, deranged, and ingenious traps.

Tobin Bell reprises the role of John Kramer / Jigsaw and is joined in the cast by Synnøve Macody Lund (Ragnarok), Steven Brand (The Sandman), Michael Beach (Dahmer – Monster: The Jeffrey Dahmer Story), Renata Vaca (Pedal to Medal), Paulette Hernandez (Crown of Tears), Joshua Okamoto (Control-Z), Octavio Hinojosa (How to Survive Being Single), and Smith.

Franchise producers Mark Burg and Oren Koules of Twisted Pictures provided the following statement: “What a thrill to be reuniting with Tobin. His performance as John Kramer is part of the magic that made this franchise a phenomenon and his character is an active part of this film.” They have previously said, “We have been listening to what the fans have been asking for and are hard at work planning a movie that Saw aficionados and horror fans alike will love.”

A press release from Lionsgate says “the return of Bell to the franchise furthers Lionsgate and Twisted Pictures’ goal of a film that captures everything Saw fans love about the franchise, while also keeping them guessing with all-new traps and a new mystery to solve.”

Deadline reminds us that Bell’s Kramer (otherwise known as Jigsaw) is “the antagonist at the heart of the Saw franchise – a former civil engineer who was diagnosed with colon cancer and subsequently elected to test others’ will to live via a series of deadly games. The character appeared in the first three Saw films before being killed off, then going on to appear via flashbacks in most of the films that followed.”

Are you looking forward to Saw X, and are you glad to see Shawnee Smith back in the role of Amanda Young? Share your thoughts on this one by leaving a comment below.



Originally published at https://www.joblo.com/saw-x-shawnee-smith/

Lung Cancer Research Foundation (LCRF) Joins Carebox Connect Network

By
NT Editor
-
0
Lung Cancer Research Foundation (LCRF) Joins Carebox Connect Network
Carebox to help LCRF advance lung cancer research by making it easier and more effective for patients, caregivers and healthcare professionals to identify relevant lung cancer trials.

NEW YORK and RALEIGH, N.C., August 1, 2023 (Newswire.com) - Carebox, a leading provider of clinical trial matching solutions, and the Lung Cancer Research Foundation (LCRF), a leading nonprofit organization focused on research to extend survival and improve quality of life for people with lung cancer, today announced the launch of a Carebox Connect experience optimized for lung cancer patients. 

From the clinical trials page of the LCRF website, lung cancer patients, their caregivers and healthcare professionals can visit the Carebox Connect web application for an easy and effective way to search for and match to potentially relevant trials. By making this search resource available on its website, LCRF is connecting patients to research and enabling them to make the best treatment decisions for themselves.  

Visitors to the web application can complete a 10-question questionnaire about the patient's lung cancer condition and then instantly see which of over 1,000 actively recruiting clinical trials with treatment options are potentially relevant for them. They can then get connected to a trial research site for next steps. 

The Carebox Connect trial database is synchronized daily with the ClinicalTrials.gov clinical trial data maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). Applying its human-supervised AI, Carebox converts the unstructured text in ClinicalTrials.gov that describes eligibility criteria for enrollment into a searchable index of clinical criteria for matching with patient characteristics.

"Carebox Connect enables us to both advance research and make clinical trial treatment options much more accessible to the lung cancer patient community." 
-Aubrey Rhodes, Executive Director of LCRF

For more advanced users, full search and filtering capabilities are available. Filters can be saved for future use. Furthermore, based on those saved filters, users can subscribe to receive Carebox Connect notifications in their email inbox whenever new trials open (or new sites open) in a defined distance radius from where they are located. 

"LCRF is on a mission to improve lung cancer outcomes by funding research for prevention, diagnosis, treatment and cure. Patient participation in clinical trials is a critical component on the road to our vision of a world free of lung cancer," explains Aubrey Rhodes, Executive Director of LCRF, adding that "Carebox Connect enables us to both advance research and make clinical trial treatment options much more accessible to the lung cancer patient community."  

"The Carebox Connect Network has a common technology foundation and a unified end-user application," notes Assaf Levi, Carebox VP of R&D. "However, we can create customized experiences for each specific condition so that lung cancer patients arriving from LCRF are directed to the relevant questionnaire and trials for them. Knowing that we are touching the lives of so many patients and can help support efforts of organizations like LCRF in advancing such important research, is core to what makes working at Carebox special for the entire engineering team."

About the Lung Cancer Research Foundation 

The Lung Cancer Research Foundation® (LCRF) is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. LCRF's mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment, and cure of lung cancer. To date, LCRF has funded 409 research grants, totaling nearly $42 million, the highest amount provided by a nonprofit organization dedicated to funding lung cancer research. For more information, visit LCRF.org. 

About Carebox 

Carebox connects patients and physicians seeking treatment options with clinical trials. For patients and families, access to information about the newest and most advanced treatment options is obscured and frustrating to find. For pharma companies, clinical trial recruitment is the primary bottleneck in the $100B+ drug development market now being reshaped by precision medicine treatment specificity, new trial models, diversity requirements, and digital health consumer expectations. Carebox is at the forefront of addressing these challenges for patients and their families, as well as for the ecosystem of companies involved in sponsoring, running, and recruiting for clinical trials.  

Learn more about Carebox at careboxhealth.com. 

About Carebox Connect 

The Carebox Connect cloud platform digitizes Carebox's two decades of experience in navigating over one million patients seeking clinical trial options. It enables trial sponsors of all sizes to educate, engage, navigate, match, qualify, refer, and enroll patients in their clinical trials. Pharma trial sponsors, hospital research centers, and patient advocacy groups use Carebox Connect to present their clinical trial portfolios to the public, optimize trial recruitment, and enhance participant diversity in support of ongoing clinical research. 

About The Carebox Connect Network 

In addition to customer-branded Carebox Connect solutions for trials sponsors and sites, the Carebox Connect Network brings the power of the platform to patients, families, and caregivers via a rapidly growing network of dozens of patient advocacy groups and physician associations reaching tens of thousands of patients. Carebox runs co-branded and branded web applications and/or clinical trial navigation services on behalf of its Carebox Connect Network partners.  

Contact Information:
Karen Shemesh
Marketing
[email protected]
1-866-914-7345


Original Source: Lung Cancer Research Foundation (LCRF) Joins Carebox Connect Network

Essex Cardiothoracic Centre Earns Award for Atrial Fibrillation Study That Demonstrates StatSeal Efficacy

By
NT Editor
-
0
Essex Cardiothoracic Centre Earns Award for Atrial Fibrillation Study That Demonstrates StatSeal Efficacy
Study demonstrates efficacy of StatSeal® Advanced Plus Disc use for groin closure following atrial fibrillation ablation procedures to treat patients with irregular heartbeats.

SARASOTA, Fla., August 1, 2023 (Newswire.com) - The acclaimed Essex Cardiothoracic Centre, part of Mid and South Essex NHS Foundation Trust, was recognized with an award following their cutting-edge clinical study that evaluated a novel groin closure method to allow rapid same-day discharge following atrial fibrillation (AF) ablation procedures to treat patients with irregular heartbeats.

The study evaluated using the StatSeal® Advanced Plus Disc (Biolife, LLC) for femoral vein groin closure of AF ablation patients who remained on their anticoagulation medications. The previous closure method used was physician-placed sutures. During the study, 50 AF ablations were performed, and StatSeal Advanced Plus Disc was applied to the groin closure site by technicians, not the physicians, with only 5 to 10 minutes of manual pressure. The median recovery time for the StatSeal group was just 2 hours, compared to 4 hours with the suture closure method. The median discharge time for the StatSeal group was only 2.5 hours, compared to 5 hours with the suture closure method. StatSeal use resulted in a more than 50% decrease in recovery time, with no rise in complications, allowing patients to safely mobilize and get home earlier compared to the suture closure method. The study concluded that StatSeal use will likely lead to increased same-day discharge and fewer overnight stays following AF ablations.

As a result of this study, which demonstrates the efficacy of StatSeal use for groin closure, the Essex Cardiothoracic Centre has been recognized globally as a Centre of Excellence for Atrial Fibrillation by the Atrial Fibrillation Association. The study was published in the 2023 AF Healthcare Pioneer Report, which can be found online at: https://api.heartrhythmalliance.org/files/download/621e9388e8269ecaa50c07a133797450

Lead investigator Rhoel Peralta, Cath Lab Associate Practitioner at MSE Hospitals, commented, "Our efforts and success prove that we can all play our part for patients and make a difference, and this acknowledgment reinforces our commitment to providing exceptional care to our patients. We are thrilled to be recognized as a Centre of Excellence and AF Healthcare Pioneers. I am part of a much larger team where everyone came together and worked tirelessly."

Biolife, LLC

Biolife, LLC is a privately-owned medical device company headquartered in Sarasota, Florida, that manufactures innovative healthcare and first aid solutions that stop bleeding fast and improve patient outcomes. All Biolife products are comprised of a powder with two main ingredients: potassium ferrate and a hydrophilic polymer. The products work independently of the clotting cascade to seal the wound or procedural site, while accelerating hemostasis. The low pH seal created by the powder helps reduce risk of infection and helps improve recovery time. StatSeal® products for the healthcare industry are available in powder and disc (compressed powder) form to suit a wide variety of clinical applications. For more information, visit: https://www.biolife.com/

Contact Information:
Angela Augustitus
Director of Marketing
[email protected]
+1 941 360 1300 X117


Original Source: Essex Cardiothoracic Centre Earns Award for Atrial Fibrillation Study That Demonstrates StatSeal Efficacy

THIRA Health Jump-Starts Its Adolescent Residential Treatment Program

By
NT Editor
-
0
THIRA Health Jump-Starts Its Adolescent Residential Treatment Program

THIRA Health
THIRA Health Logo

BELLEVUE, Wash., August 1, 2023 (Newswire.com) - Bellevue, Washington-based mental wellness center THIRA Health is excited to announce the launch of its Adolescent Residential Treatment Program that aims to help 13- to 17-year-olds struggling with anxiety, depression, and self-harm and trauma-related disorders.

The adolescent residential treatment program is built upon creative, innovative, and actionable ways of navigating treatment. With a team of experienced practitioners, this program offers round-the-clock guidance on DBT (Dialectical Behaviour Therapy) onboarding to support participants on their journey as they build coping skills that can cultivate long-term, meaningful life changes. 

The program also includes a series of unique support such as:

  • Individualized family engagement sessions
  • Weekly multi-family skills training reviews
  • Individual therapy sessions with a DBT-trained therapist
  • Comprehensive nutrition program which will be overseen by Registered Dieticians
  • Daily emotional and physical health support by registered nurses and certified nursing assistants
  • Psychiatric medication with a team of psychiatrists and expert nurse prescribers
  • Expressive Arts with registered art therapists
  • Academics with a certified teacher
  • Mindfulness groups (including mindful movement, yoga, and qigong)
  • Therapeutic outings, equine-assisted learning, and volunteering to foster participants' sense of connection and belongingness

For more information about the program, go to https://www.thirahealth.com/rtc-housing.

About THIRA Health

THIRA Health is led by a team of experts with collective experience exceeding 100 years and a dedication to helping people strive for a life worth living. Dr. Mehri Moore is our founder and Dr. Kathryn Korslund is our CEO — both doctors guide a team of 100+ clinical and support staff. 

THIRA Health provides services ranging from residential for adolescents to intensive outpatient for ages 13+. Our commitment to the rigor of Dialectical Behaviour Therapy combined with innovative supportive treatments and medication management ensures top-tier treatment for women, teen girls and gender non-conforming individuals. 

Contact Information:
Sarah Skoterro
Director of Business Development
[email protected]
206-718-0866


Original Source: THIRA Health Jump-Starts Its Adolescent Residential Treatment Program

Introducing Propelus: Healthcare Compliance Leader Unveils New Company Brand to Focus on Powering Professionals

By
NT Editor
-
0
Introducing Propelus: Healthcare Compliance Leader Unveils New Company Brand to Focus on Powering Professionals
An extensive rebranding initiative brings together the company's three product brands - CE Broker, EverCheck, and Immuware - to offer dynamic compliance and total professional management for the nation's workforce

JACKSONVILLE BEACH, Fla., August 1, 2023 (Newswire.com) - The parent company behind leading workforce compliance management and continuing education products CE Broker, EverCheck, and Immuware, today unveiled a new corporate brand — Propelus — to unify the group's vision to "power professional progress'' through dynamic compliance for our nation's workforce. 

The new brand identity reflects significant growth transformation at the company, bringing together the Propelus product portfolio with a renewed sense of purpose to modernize how professionals, their employers, regulators, agencies, and associations work better together. The new "propeller" logo demonstrates the full lifecycle of professional progress focused on innovation, relationships, and forward momentum alongside the new name.   

Propelus (pronounced propel·us) embodies the company's dynamic market-leading technology, vital data, and dedication to streamlining and simplifying compliance for total professional management. At the heart of the rebranding initiative are the millions of healthcare and other dedicated workers serving as the inspiration behind the group's shared mission. 

"Introducing Propelus marks a significant milestone along our 20-year mission to empower professional progress throughout the career journey and, ultimately, help safeguard our communities," said Julie Walker, CEO of Propelus. "We are focused on ensuring that Propelus is synonymous with our values-driven approach to simplifying workforce compliance for better outcomes - together." 

The arrival of Propelus comes as companies in the healthcare, education, and government technology industries consolidate and require digital transformation to standardize, automate, and simplify their processes. Additionally, as technology advances to streamline, simplify, and elevate how organizations operate, Propelus creates much-needed connections between stakeholders, privileged partner relationships, and professionals with access to the most reliable, trusted, and automated data in the market.

Launching a unified website accompanies the transition to the new Propelus name. Propelus is trusted by more than 5 million professionals, employers, regulators, and partners through its suite of workforce management and compliance technology solutions.  

About Propelus 

Propelus is modernizing how professionals, their employers, regulators, and associations work better together. For over 20 years, Propelus solutions — CE Broker, EverCheck, and Immuware — have propelled the progress of millions of dedicated professionals in their career journey. Our market-leading workforce compliance management technology, full-lifecycle continuing education software, and vital data simplify total professional management for a happier workforce, better operations, and safer communities.

We power professionals. 

Learn more at www.propelus.com.

Contact Information:
Jean Chen
CMO, Propelus
[email protected]
720.445.5537


Original Source: Introducing Propelus: Healthcare Compliance Leader Unveils New Company Brand to Focus on Powering Professionals

Paul Reubens, Pee-wee Herman actor, dies at 70 after a private battle with cancer

By
NT Editor
-
0
Paul Reubens, Pee-wee Herman actor, dies at 70 after a private battle with cancer

Paul Reubens, the actor best known for portraying the child-like character Pee-wee Herman, has passed away from cancer at age 70.

Today’s secret word is sadness! Paul Reubens, the gifted actor and comedian best known for portraying Pee-wee Herman, died on Sunday at 70. According to Reubens’ estate, the red bowtie-loving ball of energy passed away after a private battle with cancer.

“Please accept my apology for not going public with what I’ve been facing the last six years,” Reubens wrote in an Instagram message posted to fans. “I have always felt a huge amount of love and respect from my friends, fans and supporters. I have loved you all so much and enjoyed making art for you.”

“Last night we said farewell to Paul Reubens, an iconic American actor, comedian, writer and producer whose beloved character Pee-wee Herman delighted generations of children and adults with his positivity, whimsy and belief in the importance of kindness,” wrote Reubens’ estate in an Instagram post “Paul bravely and privately fought cancer for years with his trademark tenacity and wit. A gifted and prolific talent, he will forever live in the comedy pantheon and in our hearts as a treasured friend and man of remarkable character and generosity of spirit.”

Where do I begin? I can scarcely think of many actors that shine from my childhood as brightly as Reubens. The word “icon” comes to mind. Still, that needs to be more significant for this titan of entertainment. Reubens joined the Los Angeles troupe The Groundlings in the 1970s, bringing his signature off-kilter comedy brand to the stage. In 1982, Reubens debuted a character he’d been developing for years, Pee-wee Herman. Reubens delighted audiences with racy gags, innuendo, and knee-slapping one-liners in his light gray suit, red bowtie, and flip hairstyle. The show sold out for five months before HBO produced a special about Reubens’ daring comedic approach.

In 1995, Reubens starred in Tim Burton’s Pee-wee’s Big Adventure, featuring the title character on a search-and-rescue mission to find his stolen bicycle. Pee-wee’s Big Adventure did gangbusters at the box office, with the feature eventually reaching cult status among disaffected youth. Big Adventure‘s sequel, Big Top Pee-wee, was released in 1988 to less acclaim. However, Between 1986 and 1990, Reubens starred in the children’s program Pee-wee’s Playhouse, a variety show featuring notable cameos from Laurence Fishburne (Cowboy Curtis), Phil Hartman (Captain Carl), Natasha Lyonne (Opal), Jimmy Smits (Johnny Wilson), and a neverending roster of celebrity guests.

After several quiet years, Reubens re-emerged with one of my favorite comedies of all time, Kinka Usher’s Mystery Men. Reubens plays the gross-out hero Spleen in the quirky superhero adaptation. With the power of super-flatulence, Spleen wields his farts with unmatched precision and grave consequences. I’m not kidding when I say Mystery Men is one of my favorite films. I’ve seen it more times than I can count and love it more with each watch.

Reubens was more than his Pee-wee persona. The larger-than-life actor also voiced Max, a spacecraft’s wise-cracking interface in Flight of the Navigator, Amilyn the vampire in Buffy the Vampire Slayer, Lock in Henry Selick and Tim Burton’s The Nightmare Before Christmas, Derek Foreal in Blow, Sir Terrence in episodes of Reno 911! Miami, the Desk Clerk in Cheech and Chong’s Next Movie, and much more!

We here at JoBlo wish Mr. Reubens safe travels to the Great Hereafter. Many childhoods at this site would not have been the same without Reubens (and, by extension, Pee-wee) making us laugh while helping shape our bizarre sense of humor. We wish Mr. Reubens’ family, friends, and fans love and healing.

Originally published at https://www.joblo.com/paule-reubens-dies/

Francis Ford Coppola says Barbenheimer points to “golden age” of moviegoing

By
NT Editor
-
0
Francis Ford Coppola says Barbenheimer points to “golden age” of moviegoing

Coppola has pointed to Barbie and Oppenheimer’s box office success as signs people want to see non-franchise movies on the big screen.

It seems so rare that the Movie Brats – the batch of New Hollywood directors who changed the game forever (for both good and bad, depending on your perspective) in the late ‘60s and ‘70s – have something positive to say about today’s cinema. But one, Francis Ford Coppola, thinks we could be in a renaissance for big screen movies, offering praise for the box office reception of, yes, Barbenheimer.

In an Instagram AMA session (yes, Coppola has Instagram; no, we can’t confirm that Sofia taught him how to use it, although he did confirm he was the one in charge of the AMA), the maestro said that the collective turnout at the movies for both Barbie and Oppenheimer, which have pulled in around $1.2 billion worldwide total so far, is a sign that people don’t just want to see major franchises on the big screen. “I have yet to see them, but the fact that people are filling big theaters to see them and that they are neither ‘sequels’ nor ‘prequels’… no number attached to them meaning they are true one-off’s is victory for Cinema.”

Based on the monumental turnout for these movies, Coppola said he is beyond hopeful for the state of the cinemagoing experience, adding, “My hunch is that we’re on the verge of a golden age wonderfully illuminating cinema seen in large theaters.” Here’s hoping his passion project, the $100+ million Megalopolis, can find the proper audience to recoup its budget, which is reportedly being financed by Coppola himself.

The 84-year-old Coppola has been outspoken against certain modern movies before, criticizing the likes of Marvel because “we expect to learn something from cinema, we expect to gain something, some enlightenment, some knowledge, some inspiration,” which he says such fare doesn’t offer. While he did continue to dismiss franchise flicks in his remarks, he is at least moving in a more positive direction with his take on the state of the box office.

Do you agree with Francis Ford Coppola that we could be heading towards a “golden age” of going to the movies? Where do you think Barbie and Oppenheimer will land on the top highest-grossing movies of 2023?

Originally published at https://www.joblo.com/francis-ford-coppola-says-barbenheimer-points-to-golden-age-of-moviegoing/

VALO Holdings Group CEO Jana Seaman and SurgeTrader Unite in Philanthropic Endeavor: The 2023 Gold Rush Rally

By
NT Editor
-
0
VALO Holdings Group CEO Jana Seaman and SurgeTrader Unite in Philanthropic Endeavor: The 2023 Gold Rush Rally
VALO Holdings Group and SurgeTrader continue to exemplify their commitment to community support and philanthropy during last month's Gold Rush Rally by handpicking a charitable organization to support at each rally leg.

NAPLES, Fla., July 31, 2023 (Newswire.com) - VALO Holdings Group CEO Jana Seaman and SurgeTrader, renowned names in the investment and trading sectors, are thrilled to announce their joint participation in the highly anticipated 2023 Gold Rush Rally, last month. Spearheaded by their CEO, Jana Seaman, the companies supported a charitable organization at every stop of the rally, spanning various cities across the western United States. This collaborative effort underscores their unwavering commitment to corporate social responsibility and their mission to create a positive impact in the communities they serve.

The Gold Rush Rally serves as an exceptional platform for VALO Holdings Group and SurgeTrader to showcase their dedication to philanthropy while reveling in the excitement of the rally. At each leg of the race, the companies met with a designated charitable organization to extend their support and make a generous donation. The following are the dates, and the respective organizations being supported:

VALO Holdings CEO Jana Seaman expressed her enthusiasm for the Gold Rush Rally and the opportunity to contribute to these deserving organizations. She stated, "We are thrilled to have been a part of the Gold Rush Rally and to support these incredible charitable organizations. We aim to make a lasting impact and inspire others to join us in giving back to our communities."

VALO Holdings and SurgeTrader's commitment to nine charitable organizations along the Gold Rush Rally route exemplifies their unwavering pledge to corporate social responsibility and their dedication to making a positive difference. By supporting these charitable organizations, they hope to inspire others to contribute to the well-being and empowerment of individuals in need.

About VALO Holdings Group: 

VALO Holdings Group is a leading global investment firm with a diverse portfolio of businesses spanning various industries. Committed to creating positive change, VALO Holdings Group focuses on strategic investments and philanthropic efforts that empower communities and drive innovation. More at https://www.valoholdings.com/ 

About SurgeTrader:

SurgeTrader, LLC is a US-based proprietary trading — or prop trading — firm, with a mission to accelerate trader funding and provide capital to profitable traders. Once traders have proven they can be profitable by passing an Audition, they become a part of the SurgeTrader-funded trader community, with access to an account funded with up to $10 million in buying power. For more information on SurgeTrader or how to become a funded trader, visit https://www.surgetrader.com. 

Contact:

Chrissa Alghini
239-944-5317
[email protected]

Contact Information:
Chrissa Alghini
Marketing Director
[email protected]
239-249-5806


Original Source: VALO Holdings Group CEO Jana Seaman and SurgeTrader Unite in Philanthropic Endeavor: The 2023 Gold Rush Rally

School of Rock 20th Anniversary Steelbook Blu-ray arrives to melt some faces this September

By
NT Editor
-
0
School of Rock 20th Anniversary Steelbook Blu-ray arrives to melt some faces this September

Let’s get rockin’! Paramount Home Entertainment is ready to raise its horns for a School of Rock 20th Anniversary Steelbook Blu-ray!

Who’s ready to feel old? School of Rock is celebrating its twentieth anniversary this September with the School of Rock 20th Anniversary Steelbook Blu-ray! Paramount Home Entertainment is pulling out all the stops for this glorious presentation, packing the release with more raised horns than a sold-out Metallica concert at Madison Square Garden!

Initially released in October 2003, Richard Linklater (Dazed and Confused, Boyhood) directs School of Rock from a script by Mike White (The White Lotus, The Good Girl, Chuck & Buck). Jack Black stars in this heartfelt, laugh-out-loud comedy with Joan Cusack (Toys, Grosse Pointe Blank), Sarah Silverman (Wreck-It Ralph, The Sarah Silverman Program), Mike White (The One and Only Ivan, Gentlemen Broncos), Miranda Cosgrove (iCarly, Despicable Me), Rivkah Reyes (Gianna, A Holiday I Do), and more!

In School of Rock, Black’s struggling musician character, Dewey Finn, poses as a substitute teacher at a prestigious school where he convinces his students to form a rock band for an upcoming Battle of the Bands. Finn doesn’t take long to forge an unbreakable bond with the kids, as their love for rock and roll leads to the ultimate school project of making musical dreams come true.

School of Rock, Jack Black, Steelbook, Blu-ray

The special features for the film’s 20th-anniversary release are as follows:

• Commentary by actor Jack Black and director Richard Linklater

• Kids’ Kommentary

• Lessons Learned on School of Rock

• Jack Black’s Pitch to Led Zeppelin

• School of Rock Music Video

• Kids’ Video Diary: Toronto Film Festival

• MTV’s Diary of Jack Black

• Dewey Finn’s History of Rock

• Theatrical Trailer

Speaking with Entertainment Tonight in a 2022 interview, Black said working on School of Rock is the highlight of his career, saying, “My best memories are just the group of kids, and how funny and great they were. It’s definitely the highlight of my career, I can say that. Honestly.”

School of Rock lives on thanks to commanding performances through Andrew Lloyd Webber’s musical adaptation. School of Rock is also a music company that strives to teach young musicians how to wield the incredible power of music. You can catch many of their performances online. It’s quite a sight to see!

Are you excited about Paramount’s School of Rock 20th Anniversary Steelbook Blu-ray? Let us know in the comments section below!

Originally published at https://www.joblo.com/school-of-rock-20th-anniversary-steelbook/

The Assistance Fund Opens New Program for Biliary Tract Cancer

By
NT Editor
-
0
The Assistance Fund Opens New Program for Biliary Tract Cancer
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Biliary Tract Cancer

ORLANDO, Fla., July 31, 2023 (Newswire.com) - The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program for people living with biliary tract cancer. The program is designed to help eligible individuals pay for their out-of-pocket medical expenses related to biliary tract cancer, such as copays, coinsurance, and deductibles.

Biliary tract cancers impact the gallbladder, bile ducts, and ampulla of Vater.[1] The cancers are difficult to diagnose; by the time symptoms like jaundice, fatigue, and belly pain appear, the cancer has advanced.

"Because reaching a diagnosis can be so difficult for people living with biliary tract cancers, ensuring their immediate access to the treatment is critical," said Danielle Vizcaino, President and CEO at The Assistance Fund. "Our Biliary Tract Cancer Copay Assistance Program will remove the financial hurdles of this process for so many patients and their families and will allow them to focus on improving their health."

"As a family member of someone who faced a biliary tract cancer diagnosis, I am intimately familiar with how daunting the journey is to finding the right treatment and navigating access to it," said Stacie Lindsey, Founder & CEO of the Cholangiocarcinoma Foundation. "With the launch of its Biliary Tract Cancer Copay Assistance Program, The Assistance Fund has forged a path for hundreds of patients to get the treatment they need and the improved quality of life it will bring."

To learn more or determine eligibility for financial support, visit tafcares.org or call (855) 309-5525 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages nearly 90 disease programs, each of which covers all the FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped nearly 180,000 children and adults access the treatment they need to stay healthy or manage a life-threatening, chronic, or rare disease. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org. 

Media Contact

Margaret Figley

Senior Director of Communications

[email protected]

[1] Mayo Clinic, "What is biliary tract cancer?," https://www.mayoclinic.org/diseases-conditions/cholangiocarcinoma/in-depth/what-is-biliary-tract-cancer/art-20544661, accessed May 2023.

Contact Information:
Margaret Figley
Senior Director of Communications
[email protected]


Original Source: The Assistance Fund Opens New Program for Biliary Tract Cancer
1...258259260...579Page 259 of 579
© Newsmag WordPress Theme by TagDiv